Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 194 clinical trials
  • None views
  • None views
  • None views
  • None views
Combination of PD-1 and VEGFR-2 Blockade for Advanced Hepatocellular Carcinoma

The aie of this clinical study is the safety and efficacy of combination therapy for HCC patients.

monoclonal antibodies
hepatitis b surface antigen
liver cancer
monoclonal protein
pneumonia
  • 0 views
  • 19 Feb, 2024
  • 1 location
Neoadjuvant PD-1 Antibody Plus Apatinib or Chemotherapy for Non-small Cell Lung Cancer

Results from a pilot clinical study reported the safety and feasibility of neoadjuvant PD-1 blockade. There are several neoadjuvant immunotherapy (NEOSTAR, LCMC3, NADIM, IMpower131) ongoing, and the preliminary results are reported in 2019 American Society of Clinical Oncology, which show promising therapeutic prospect.

anticoagulants
platinum-based chemotherapy
kidney function test
neutrophil count
aptt
  • 0 views
  • 19 Feb, 2024
  • 1 location
Asian Diabetes Outcomes Prevention Trial

The aim of this study is to identify patients with DM at high risk of CVD using elevated N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels (>125pg/mL), and (2) intensify therapy using renin-angiotensin system (RAS) antagonists, beta-blockers and sodium glucose co-transporter-2 inhibitors (SGLT2i) for primary prevention of cardiovascular events in this high-risk …

myocardial infarction
cardiovascular disease
solute carrier family 5 member 2
beta-blocker
nt-probnp
  • 0 views
  • 19 Feb, 2024
  • 1 location
Determination Safety and Tolerability of Epigenetic and Immunomodulating Drugs in Combination With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer.

A multi-center, open-label phase I/II study to to determine the safety and tolerability of Azacitidine and/or Romidepsin in combination with nab-Paclitaxel/Gemcitabine in patients with advanced pancreatic ductal adenocarcinoma (PDAC) (Part 1), followed by sequential immune targeting with programmed death-ligand (PD-L)1 blockade in combination with low-dose Lenalidomide (Part 2) in patients …

pancreatic ductal adenocarcinoma
adenocarcinoma
pdac
antineoplastic agents
drug test
  • 0 views
  • 19 Feb, 2024
  • 8 locations
Safety and Early Signs of Efficacy of IL12-L19L19.

The purpose of this study is to describe the safety, tolerability and early signs of efficacy of the antibody-cytokine fusion protein IL12-L19L19 in patients with advanced or metastatic solid carcinomas and diffuse large B-cell lymphoma (DLBCL), after previous immune checkpoint blockade therapy. The primary objective of the study is to …

melanoma
urothelial carcinoma
hypophysitis
liver cancer
cancer, hepatocellular
  • 0 views
  • 19 Feb, 2024
  • 4 locations
Erector Spinae Plane Block After Lumbar Spinal Stenosis Surgery

It involves the injection of local anesthetics into the interfascial plane, deep to erector spinae muscle, allowing the blockade of the dorsal and ventral rami of the thoracic spinal nerves. It was initially proposed for analgesia of costal fractures, pulmonary lobectomy and thoracic vertebrae.

stenosis
blockade
lumbar spinal stenosis
local anesthetic
spinal stenosis
  • 0 views
  • 19 Feb, 2024
  • 1 location